Shopping Cart
- Remove All
- Your shopping cart is currently empty
EGFR-IN-99 (JBJ-03-142-02) is an EGFR and HER2 Exon 20 insertion mutation inhibitor with antiproliferative activity for the study of non-small cell lung cancer (NSCLC).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $90 | In Stock | |
5 mg | $223 | In Stock | |
10 mg | $330 | In Stock | |
25 mg | $536 | In Stock | |
50 mg | $735 | In Stock | |
100 mg | $993 | In Stock | |
200 mg | $1,330 | In Stock |
Description | EGFR-IN-99 (JBJ-03-142-02) is an EGFR and HER2 Exon 20 insertion mutation inhibitor with antiproliferative activity for the study of non-small cell lung cancer (NSCLC). |
Synonyms | JBJ-03-142-02 |
Molecular Weight | 487.49 |
Formula | C25H22FN7O3 |
Cas No. | 2068806-31-3 |
Smiles | O=C(C=C)NC1=CC=CC(=C1)N(C(=O)OCC2=CC=C(F)C=C2)C3=NC(=NC=C3)NC=4C=NN(C4)C |
Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
Solubility Information | DMSO: 1 mg/mL (2.05 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.